Product NDC: | 0091-3321 |
Proprietary Name: | Niravam |
Non Proprietary Name: | alprazolam |
Active Ingredient(s): | .25 mg/1 & nbsp; alprazolam |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, ORALLY DISINTEGRATING |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0091-3321 |
Labeler Name: | Schwarz Pharma Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021726 |
Marketing Category: | NDA |
Start Marketing Date: | 20050120 |
Package NDC: | 0091-3321-01 |
Package Description: | 100 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (0091-3321-01) |
NDC Code | 0091-3321-01 |
Proprietary Name | Niravam |
Package Description | 100 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (0091-3321-01) |
Product NDC | 0091-3321 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | alprazolam |
Dosage Form Name | TABLET, ORALLY DISINTEGRATING |
Route Name | ORAL |
Start Marketing Date | 20050120 |
Marketing Category Name | NDA |
Labeler Name | Schwarz Pharma Inc. |
Substance Name | ALPRAZOLAM |
Strength Number | .25 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Benzodiazepine [EPC],Benzodiazepines [Chemical/Ingredient] |